Why is NAMS Down Today?
About NewAmsterdam Pharma Company N.V. Ordinary Shares
NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor...
Overall Confidence: 65%
Based on news, social sentiment, options activity, and sector analysis
✅ Move Confirmation
UNCONFIRMED - Low volume suggests this move may not be sustainable.
📍 Sector Context
PHARMACEUTICAL PREPARATIONS sector: -1.6%
Market Comparison
Quick Trade Ideas
Options strategies to consider for NAMS's -5% move
No Options Available
NAMS doesn't have listed options or options data is currently unavailable.
Try another stock in our Options Calculator →🔔 Get NAMS Alerts
We'll notify you when NAMS's trend changes or a new signal fires.
Data refreshes every 30 minutes during market hours
Historical Context
NAMS has moved more than 3.0% down on 46 occasions in the past year.
Frequently Asked Questions
Why is NAMS stock down today?
This appears to be a sector-wide move. The PHARMACEUTICAL PREPARATIONS sector is down 1.6% on average.
Is NAMS stock a buy or sell right now?
Based on current analysis, NAMS shows 65% confidence in today's move. Volume is low which does not confirm the trend. View full buy/sell analysis →
What is the NAMS stock price target?
NAMS is currently trading at $22.89. Based on today's momentum, the expected short-term range is $22.20 - $23.35. See long-term price prediction →
Will NAMS stock continue falling?
Our analysis shows a 45% probability that NAMS's move continues in the next 1-3 days. Key level to watch: $21.75 (support).
Is NAMS stock oversold or overbought?
NAMS's RSI (Relative Strength Index) is currently at 44.2. This shows bearish momentum - the stock has negative momentum but isn't oversold yet.
What is the momentum for NAMS stock?
NAMS's 10-day momentum indicator is at 0.71. Positive momentum - the stock has mild upward pressure supporting the current trend.
Is NAMS outperforming or underperforming the market?
NAMS (-5.26%) is currently significantly underperforming the market (-6.0% vs SPY). Today, the S&P 500 (SPY) is up 0.74%, and Nasdaq (QQQ) is up 1.02%.
What does MACD indicate for NAMS?
NAMS's MACD (-0.67) is currently above the signal line (-1.04), indicating a bullish trend. This technical signal suggests buying pressure is dominant. The trend strength (ADX: 30.9) is strong.
Is NAMS in an uptrend or downtrend?
Based on moving average analysis, NAMS is in a mixed/transitional trend. The price and moving averages are not clearly aligned, suggesting a potential trend change or consolidation phase. 20-day SMA: $23.03, 50-day SMA: $25.64.
Check Why Another Stock is Moving
Enter any ticker symbol to see real-time analysis